Pediatric drug trials: women and children last?
Shneider
B L
BL
D000328:Adult; D000998:Antiviral Agents / Q000627:therapeutic use*; D002648:Child; D002986:Clinical Trials as Topic; D017277:Drug Approval; D004359:Drug Therapy, Combination; D005260:Female; D019694:Hepatitis B, Chronic / Q000188:drug therapy*; D006526:Hepatitis C / Q000188:drug therapy; D006801:Humans; D016898:Interferon-alpha / Q000627:therapeutic use*; D018579:Patient Selection; D012254:Ribavirin / Q000627:therapeutic use; D014481:United States; D014486:United States Food and Drug Administration
D000998:Antiviral Agents; D016898:Interferon-alpha; D012254:Ribavirin